Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2011 Jan 31;6(1):e16310. doi: 10.1371/journal.pone.0016310

Non-Sexual Transmission of Trichomonas vaginalis in Adolescent Girls Attending School in Ndola, Zambia

Tania Crucitti 1,*, Vicky Jespers 2, Chanda Mulenga 3, Shepherd Khondowe 3, Judith Vandepitte 4, Anne Buvé 2,¤
Editor: Landon Myer5
PMCID: PMC3031561  PMID: 21305023

Abstract

Objectives

To identify risk factors for trichomoniasis among young women in Ndola, Zambia.

Method

The study was a cross-sectional study among adolescent girls aged 13-16 years in Ndola, Zambia. Study participants were recruited from schools in selected administrative areas that represented the different socio-economic strata in town. Consenting participants were interviewed about their socio-demographic characteristics; sexual behaviour; and hygiene practices. Self-administered vaginal swabs were tested for Trichomonas vaginalis. HSV-2 antibodies were determined on serum to validate the self-reported sexual activity.

Results

A total of 460 girls participated in the study. The overall prevalence of trichomoniasis was 27.1%, 33.9% among girls who reported that they had ever had sex and 24.7% among virgins. In multivariate analysis the only statistically significant risk factor for trichomoniasis was inconsistent use of soap. For the virgins, none of the risk factors was significantly associated with trichomoniasis, but the association with use of soap (not always versus always) and type of toilet used (pit latrine/bush versus flush toilet) was of borderline significance.

Conclusion

We found a high prevalence of trichomoniasis in girls in Ndola who reported that they had never had sex. We postulate that the high prevalence of trichomoniasis in virgins in Ndola is due to non-sexual transmission of trichomoniasis via shared bathing water and inconsistent use of soap.

Introduction

T. vaginalis is a flagellated eukaryotic organism responsible for the commonest curable sexually transmitted infection worldwide with nearly 170 million new cases each year [1]. Infection with T. vaginalis may present as an asymptomatic infection or an inflammatory disease. The parasite may cause vaginitis, cervicitis, and urethritis [2].The infection has been associated with pelvic inflammatory disease, adverse pregnancy outcome, and increased risk of acquisition and transmission of HIV infection [3][5].

At a symposium on Trichomonas infections in Rheims in 1957, the majority of delegates agreed that trichomoniasis was usually transmitted by sexual intercourse and that it should be regarded as a venereal disease [6].There is no doubt that sexual transmission predominates and is the most important mode of transmission of trichomoniasis. However, there are several reports of non-sexual transmission. Adu-Sarkodie reported probable transmission of T. vaginalis within a family in Ghana and hypothesized that transmission occurred from the mother to her children through the sharing of bathing implements [7]. Charles described an epidemic of trichomoniasis in young girls in a rural area in India. He suggested that transmission had occurred through contaminated water [8]. T. vaginalis can indeed survive outside the human body in a wet environment for more than three hours [9][11].

In 1997–1998 a population-based study was conducted in four African cities, two in West Africa (Cotonou in Benin and Yaoundé in Cameroon) and two in East Africa (Kisumu in Kenya and Ndola in Zambia) to identify factors that could explain the differences in the rate of spread of HIV between different regions in sub-Saharan Africa [12]. The prevalence of T. vaginalis infection was much higher in the two East African cities [13]. The most striking finding however was the high prevalence of trichomoniasis in women in Ndola (Zambia) who denied that they had ever had sexual intercourse. The prevalence of trichomoniasis was 40% among women who denied sexual activity, whereas in the other cities the prevalence ranged between 2.9% and 7.7%. We hypothesized that in Ndola non-sexual transmission of T. vaginalis is very frequent.

We decided to explore this issue and to conduct further research on the epidemiology of trichomoniasis in women in Ndola. This paper presents the results of the study which we conducted among young girls aged 13 to 16 years. The objective of this study was to identify risk factors for trichomoniasis among young women in Ndola.

Methods

Ethical Committee

The study was approved by the Ethics Committees of the Tropical Diseases Research Centre in Ndola and the Institute of Tropical Medicine in Antwerp.

Study Design and Sample

We set out to compare the prevalence of trichomoniasis in young girls who were sexually active and young girls who were not sexually active, and took the age range of 13 to 16 years for our study population. Study participants were recruited from schools where permission was obtained from the headmaster and teaching staff. A meeting was then organized with research staff and girls aged 13–16 years during which the study was explained. Girls who were interested in participating in the study were given an appointment for the informed consent procedure. Informed consent for an interview and the collection of specimens was first sought from the parents or guardians. Girls could participate in the study only when written consent was obtained from the parents or guardian and assent from the girls themselves.

Assenting study participants were interviewed face-to-face by a trained interviewer about their socio-demographic characteristics, sexual behaviour, and hygiene practices. The girls were asked to submit two self-collected swabs: a cotton swab that was immediately inoculated in a culture medium (InPouch, Biomed Diagnostics, San Jose, California) and kept at room temperature, and a BD BBL CultureSwab EZ (Becton Dickinson BBL, Maryland, MD, USA) which was kept in a cool box. A study nurse took a 10cc blood sample which was kept at room temperature. All specimens were transported to the laboratory within seven hours of collection.

The face-to-face interview and specimen collection were carried out either at the home of the girl or at the school and in the absence of parents, guardians or teachers. The girls received an appointment at the Tropical Diseases Research Centre clinic (TDRC), where they could collect their results of the trichomoniasis test and receive treatment free of charge.

Laboratory procedures

Upon arrival at the laboratory of the TDRC, the BD BBL CultureSwabs EZ were stored at −20°C until shipment. InPouch culture media were incubated at 37°C and examined for the characteristic trichomonad morphology and motility up to seven days after inoculation. After final reading, the pouches were stored at −80°C until shipment.

The blood specimens were centrifuged and the sera were kept at −20°C at the TDRC, until shipment. All specimens were shipped on dry ice to the Institute of Tropical Medicine in Antwerp (ITM), Belgium.

At the ITM the vaginal swab specimens were tested for T. vaginalis by polymerase chain reaction (PCR). After thawing the swabs at room temperature for 30 minutes, 1250 µl diluted PBS [pH 7.4] were added to the swab and gently vortexed for at least 15 seconds. Aliquots of 250 µl were extracted using the QIAamp® DNA minikit (Qiagen, Hilden, Germany), following the manufacturer's instructions. The extracted DNA was eluted with 250 µl of Tris-acetate-EDTA -buffer [pH 7.4]. For the amplification of T. vaginalis we used TVK3/7 primers, and positive results were confirmed using IP1/IP2 primers [14], [15]. Specimens that tested positive on the two different primer sets were considered to be true positive.

The T. vaginalis amplicons were detected using an enzyme immuno assay (EIA). The PCR assays were performed as described elsewhere [16].

The β2 microglobulin gene amplification was carried out on each vaginal specimen to control for PCR inhibition [16]. In order to validate the InPouch microscopical readings, 500 µl of all InPouch media were extracted and tested for T. vaginalis by PCR as described above.

The serum specimens were tested for antibodies against HSV-2 (Kalon Biological Ltd, Surrey, UK), following the manufacturer's instructions.

Data analysis

Study participants were considered to be infected with T. vaginalis if the InPouch culture was positive, or if the PCR result on the InPouch or on the swab was positive, using the two different primer sets. Study participants were considered to be virgins if they reported that they had never had sexual intercourse and if the serum sample was negative for antibodies against HSV-2. Girls who denied that they had ever had sexual intercourse and were positive for HSV-2 infection were excluded from the risk factor analysis.

The following risk factors for trichomoniasis were explored in bivariate analysis: age; socio-economic status of the area of residence; bathing facilities; use of soap when bathing; sharing of bathing implements; type of toilet; sharing of bed; sexual activity; HSV-2 infection. Factors that were significantly associated with trichomoniasis at the 0.1 level, as well as age, were included in a multivariate regression model. All data analyses were done using SPSS for Windows version 15.0.

Results

A total of 460 girls aged 13–16 years participated in the study. We could establish the presence or absence of T. vaginalis infection in 439 girls. Fifteen girls did not submit a sample and samples of another 6 girls gave inconclusive results due to PCR inhibition. InPouches of 5 girls could not be retrieved.

Table 1 describes the socio-economic characteristics, hygiene practices and sexual behaviour of the 460 girls. Twenty three percent of the girls lived in a poor or very poor area of town. Very poor areas of town lacked running water or electricity, poor areas of town had running water and pit latrines but the general socio-economic status of the residents was low. Nearly all girls took a bath or washed their body daily, and the majority (75%) used a basin. Soap was always used for washing by 70%, and 45% of the girls used soap inside the vagina. More than half of the girls used a flush toilet. Seventy-three percent of the girls reported that they shared their bedding with someone else, most often a sister or the mother. There was no significant difference in the proportion of girls who shared their bed according to whether they slept in a bed, on a mattress or on a mat (data not shown).

Table 1. Characteristics of the study population.

N = 460 %
Socio-economic status
Age 13 164 35.7
14 111 24.1
15 82 17.8
16 103 22.4
Religion Christian 450 98.0
Other 9 2.0
Earning an income Yes 28 6.1
No 431 93.9
Area of residence Better off 353 76.7
Very poor/poor 107 23.3
Hygiene practices and sleeping arrangements
Facilities for washing Tub 58 12.6
Shower 58 12.6
Basin 343 74.6
Other 1 0.2
Frequency of bathing or washing the whole body Daily 449 97.6
Less than daily 11 2.4
Use of soap when washing Always 323 70.2
Often 111 24.1
Rarely 26 5.7
Uses soap inside the vagina Yes 206 44.8
No 254 55.2
Shares towels Yes 245 53.3
No 210 46.2
Type of toilet used Flush toilet 255 55.4
Private pit latrine 155 33.7
Shared pit latrine 46 10.0
Bush 4 0.9
Sleeps on… Bed 232 50.4
Mattress 115 25.0
Mat 94 20.4
Other 19 4.1
Shares the bed, mattress … Yes 336 73.0
No 124 27.0
Sexual activity and reproductive health
Has started menstruating No 154 33.6
Yes 304 66.4
Sexual intercourse reported No 397 86.3
Yes 63 13.7
Sexual activity reported or HSV-2 positive No 380 82.6
Yes 80 17.4
Number of lifetime sex partners (reported by those who reported sexual activity) 1 43 72.9
2 9 15.3
3 3 5.0
4 4 6.8
Abnormal vaginal discharge No 410 89.7
Yes 47 10.3

Not all numbers tally due to missing information.

Sixty-three girls (13.7%) reported that they had ever had sexual intercourse with the majority (73%) reporting 1 lifetime sex partner. Of the 397 girls who denied that they had ever had sex, 17 (4%) had HSV-2 antibodies, suggesting initiation of sexual activity. If we include these 17 girls in the group of ‘ever had sex’ the total percentage of girls who ever had sex was 17.4%.

The overall HSV-2 prevalence among the adolescent girls in this study was 5.5% (25/450).

Of the 439 samples available for analysis, 79 were positive on InPouch, 37 were positive on PCR on the swab but negative on the InPouch and 3 were positive on the PCR on the InPouch. The overall prevalence of T. vaginalis infection was 27.1% (119/439). Fourteen (11.7%) of the 119 girls with T. vaginalis infection complained of vaginal discharge and 10 (8.4%) complained of a bad smell and/or dysuria. The prevalence of complaints was not significantly different among girls with or without trichomoniasis (29.8% vs. 26.7%). Complaints were also not more frequent among girls who had a positive InPouch compared to girls who were only positive on PCR.

Table 2 presents risk factors for T. vaginalis infection. In univariate analysis trichomoniasis was associated with taking a bath in a basin as opposed to using a shower or a bath tub. Girls who used soap all the time were less likely to have trichomoniasis. Furthermore trichomoniasis was associated with using a pit latrine or the bush as opposed to a flush toilet. Among the girls who reported that they had ever had sex prevalence of trichomoniasis was 33.9% and among the virgins it was 24.7%. This difference was of borderline significance. Among the girls who reported they had ever had sex T. vaginalis infection was not associated with higher numbers of lifetime sex partners but trichomoniasis was associated with HSV-2 infection. In multivariate analysis the only statistically significant risk factor for T. vaginalis was inconsistent use of soap. Sexual activity was not significantly associated with trichomoniasis and the association with HSV-2 infection was of borderline significance. Among the virgins a borderline association of T. vaginalis infection with infrequent use of soap, OR 1.6 (95% CI: 0.9 – 2.7) and type of toilet, OR 1.6 (95% CI: 0.9 – 2.7) was present.

Table 2. Risk factors for T. vaginalis infection.

N = 439 % T. vaginalis OR Unadjusted P value Adjusted OR Adjusted P value
Age 13 23.9% (38/159) 1 0.6 1 0.2
14 26.6% (29/109) 1.2 (0.7–2.0) 1.2 (0.7–2.3)
15 29.7% (22/74) 1.3 (0.7–2.5) 1.6 (0.9–3.2)
16 30.9% (30/97) 1.4 (0.8–2.5) 1.5 (0.8–2.9)
Area of residence1 Better off 23.5% (66/281) 1 0.6
Poor/very poor 28.9% (24/83) 1.3 (0.8–2.1)
Facilities for washing Tub/shower 18.0% (20/111) 1 0.01 1 0.11
Basin/other 30.2% (99/328) 2.0 (1.1–3.4) 1.6 (0.9–2.9)
Use of soap when washing Always 24.3% (75/309) 1 0.04 1 0.07
Often/rarely 33.8% (44/130) 1.6 (1.0–2.5) 1.6 (1.0–2.6)
Uses soap inside the vagina Yes 27.3% (54/198) 1 0.9
No 27.0% (65/241) 1.0 (0.7–1.6)
Shares towels1 No 28.7% (58/202) 1 0.6
Yes 26.3% (61/232) 0.9 (0.6–1.4)
Type of toilet used Flush toilet 22.4% (54/241) 1 0.02 1 0.30
Pit latrine/bush 32.8% (65/198) 1.7 (1.1–2.6) 1.3 (0.8–2.1)
Sleeps on… Bed/mattress 25.0% (82/328) 1 0.09 1 0.27
Mat/other 33.3% (37/111) 1.5 (0.9–2.4) 1.4 (0.8–2.3)
Shares the bed, mattress … No 29.8% (36/121) 1 0.4
Yes 26.1% (83/318) 0.8 (0.5–1.3)
Has started menstruating1 No 26.5% (40/151) 1 0.8
Yes 27.6% (79/286) 1.1 (0.7–1.7)
Ever had sex* No 24.7% (90/364) 1 0.14 1 0.9
Yes 33.9% (20/59) 1.6 (0.9–2.8) 1.1 (0.5–2.1)
Number of lifetime sex partners1 0 24.7% (90/364) 1 0.5
1 33.3% (13/39) 1.5 (0.8–3.1)
>1 31.3% (5/16) 1.4 (0.5–4.1)
HSV-2 positive1 No 25.1% (102/407) 1 0.004 1 0.06
Yes 58.3% (14/24) 4.2 (1.8–9.7) 4.7 (0.9–23.4)

*Girls who denied that they had ever had sex and were HSV-2 positive were excluded.

1

The total differs from 439 because of missing data for this factor.

Discussion

This study confirms our previous finding of a high prevalence of trichomoniasis in women in Ndola who report that they had never had sex [13]. In the study of 1996–1997 we found an overall prevalence of 40% among women aged 15–49 years who never had sexual intercourse [13]. Among women who denied sexual activity and were HSV-2 negative, the prevalence of trichomoniasis was 36.4% (24/66) in the adult group and 44.8% (13/29) among girls aged 15-16 years (A. Buvé, personal communication). In the present study we found a lower prevalence among girls who reported they had never had sex, 24.7% in the age group 13–16 years and 26.6% in the age group 15–16 years. The lower prevalence of trichomoniasis in this study can be explained by the fact that all the girls in this study were attending school, whereas in the previous study women were recruited from the general population and were probably on average of lower socio-economic status.

It is well known that self reported data on sexual behaviour are not reliable. The first possible explanation for our finding is that young girls have underreported their sexual activity. However it is highly unlikely that this is the only explanation for the high prevalence of trichomoniasis in girls who stated that they had never had sex. The prevalence of trichomoniasis in girls who reported that they had initiated sexual activity was 33.9%. If we assume that trichomoniasis is only transmitted through sexual intercourse, then, in order to find a prevalence of 24.7% among girls who said they had never had sex, we would have to accept that 78% of all girls aged 13 to 16 years in Ndola ever had sex and that the median age at first sexual intercourse is well below 13 years. This is rather unlikely and in contrast with the results of recent surveys on sexual behaviour in Zambia. In those surveys 14% of young women in urban areas reported that they had their first sexual experience before the age of 15 years, and the median age at first sexual intercourse was 17 years (http://www.measuredhs.com/hivdata/surveys) [17].

Buvé et al. suggested that trichomoniasis in virgins might be due to colonisation of the vagina by the intestinal parasite Pentatrichomonas. hominis, which is very difficult to distinguish from T. vaginalis on microscopic examination [13]. We rejected this hypothesis in a previous publication and confirmed the earlier findings of a study conducted by Adu-Sarkodie et al. in Ghana [18], [19]. The authors concluded that in their study population P. hominis played no role in vaginal trichomoniasis.

We postulate that the high prevalence of trichomonas infection in young girls in Ndola who reported to be virgins, is due to frequent non-sexual transmission of trichomoniasis. In the analysis of risk factors, the only factor that was statistically significantly associated with trichomoniasis, was infrequent use of soap. In addition the risk of trichomoniasis was increased in girls who used a basin for washing but this association was only of borderline significance. Risk of trichomoniasis was also increased, but not significantly, in girls who used a pit latrine or the bush as opposed to a flush toilet and in girls who slept on a mat instead of a bed or mattress. These results suggest that transmission of T. vaginalis may occur during bathing. We hypothesise that bathing in water that is shared with other women in the household is a route of non-sexual transmission of T. vaginalis in young girls. Another possible route of transmission may be manipulation of the genitals of the young girls by an older woman or by other girls who are themselves infected. Elongation of the labia is traditionally practised by people in Zambia as part of preparations for marriage. Unfortunately we did not collect any data on this practice. But a case of transmission of T. vaginalis following manipulation of the genitals by a traditional healer has recently been reported from the Gambia [20].

Although trichomoniasis is very prevalent worldwide, there is still some uncertainty about its significance in terms of morbidity and mortality [21]. Several studies have found trichomoniasis to be associated with an increased risk of acquiring HIV infection [5], [22]. A meta-analysis published in 2001 found an effect of trichomoniasis on HIV acquisition of 1.5 (95%CI: 1.2–1.9) [23]. A recent publication of a nested-case control study demonstrated a strong association between vaginal trichomoniasis and subsequent acquisition of HIV infection (adjusted OR, 2.74; 95% CI, 1.25–6.00) [24]. There is also mounting evidence that infection with T. vaginalis increases the risk of onward transmission of HIV. In Malawi HIV infected men with urethritis due to T. vaginalis were found to have an increased concentration of HIV virus particles in the semen [25]. A more recent study showed that treatment of trichomoniasis was able to reduce the HIV-1 RNA vaginal levels, confirming the findings of a previous study [26], [27]. However, more research is needed on the role of T. vaginalis infection in acquisition and transmission of HIV. In the study in Ndola conducted in 1996–1997 we found that 16% of girls in the general population aged 15–19 years were HIV infected [12]. The reasons for this high prevalence of HIV infection in young girls are not entirely clear. HSV-2 infection may play an important role in increasing the vulnerability of young girls for HIV, but we can not exclude trichomoniasis as a risk factor in these girls. These observations call for better screening for T. vaginalis and treatment, especially in young and vulnerable women.

In conclusion, we confirmed the high prevalence rate of T. vaginalis among young girls in Ndola who denied that they had ever had sex. We have not been able to identify the routes of transmission and further studies are needed to improve our understanding of the routes of transmission of T. vaginalis.

Acknowledgments

We are indebted to all interviewers from the TDRC who walked long distances to find the homes of the participants. We thank the laboratory staff and in particular Ireen Nyoni from the TDRC laboratory, and Said Abdellati, Vicky Cuylaerts, Bénédicte De Deken, and Hilde Smet from the ITM laboratory.

We are also very grateful to David Mwakazanga, the field and data entry supervisor at TDRC. We thank all study participants.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: This study was made possible thanks to a grant from the Directorate General for Development Cooperation of the Belgian Government (AIDS Impuls Fonds n°904100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Gerbase AC, Rowley JT, Heymann DHL, Berkley SF, Piot P. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Inf. 1998;74:S12–S16. [PubMed] [Google Scholar]
  • 2.Fouts A, Kraus SJ. Trichomonas vaginalis reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis. 1980;41:137–143. doi: 10.1093/infdis/141.2.137. [DOI] [PubMed] [Google Scholar]
  • 3.Cates W, Joesoef RJ, Goldman M. Atypical pelvic inflammatory disease: can we identify clinical predictors? Am J Obstet Gynecol. 1993;169:341–346. doi: 10.1016/0002-9378(93)90085-w. [DOI] [PubMed] [Google Scholar]
  • 4.Cotch MF, Pastorek JG, Nugent RP, Hiller SL, Gibbs RS, et al. Trichomonas vaginalis associated with low birth weight and pre-term delivery. Sex Transm Infect. 1997;24:353–360. doi: 10.1097/00007435-199707000-00008. [DOI] [PubMed] [Google Scholar]
  • 5.McClelland RS, Sangaré L, Hassan WM, Lavreys L, Mandaliya K, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis. 2007;195:698–702. doi: 10.1086/511278. [DOI] [PubMed] [Google Scholar]
  • 6.Anonymous Trichomonas infections. Lancet. 1957:1239–1240. [Google Scholar]
  • 7.Adu-Sarkodie Y. Trichomonas vaginalis transmission in a family. Genitourin Med. 1995;71:199–200. doi: 10.1136/sti.71.3.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Charles SX. Epidemiology of trichomonas vaginalis (TV) in rural adolescent and juvenile children. J Trop Pediatr. 1991;37:90. doi: 10.1093/tropej/37.2.90. [DOI] [PubMed] [Google Scholar]
  • 9.Burch TA, Rees CW, Reardon LV. Epidemiological studies on human trichomoniasis. Am J Trop Med Hyg. 1959;8:312–318. doi: 10.4269/ajtmh.1959.8.312. [DOI] [PubMed] [Google Scholar]
  • 10.Chappaz G, Bertrand P, Freal Cl. Critique des possibilités de contamination extra-vénérienne de la trichomonase uro-génitale. De la contamination par les niges et les sous-vêtements. Rev Fr Gynecol Obstet. 1961;56:677–684. [Google Scholar]
  • 11.Krieger H, Kimmig P. Survival ability of Trichomonas vaginalis in mineral baths. Gesundheitswesen. 1995;57:812–819. [PubMed] [Google Scholar]
  • 12.Buvé A, Caraël M, Hayes RJ, Auvert B, Ferry B, et al. Multicentre study factors determining differences in rate of spread of HIV in sub-Saharan Africa: methods and prevalence of HIV infection. AIDS. 2001;15:S5–S14. doi: 10.1097/00002030-200108004-00002. [DOI] [PubMed] [Google Scholar]
  • 13.Buvé A, Weiss HA, Laga M, Van Dyck E, Musonda R, et al. The epidemiology of trichomoniasis in women in four African cities. AIDS. 2001;15:S89–S96. doi: 10.1097/00002030-200108004-00010. [DOI] [PubMed] [Google Scholar]
  • 14.Kengne P, Veas F, Vidal N, Rey J-L, Cuny G. Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol. 1994;40:819–831. [PubMed] [Google Scholar]
  • 15.Shaio M-F, Lin P-R, Liu J-Y. Colorimetric one-tube nested PCR for detection of Trichomonas vaginalis in vaginal discharge. J Clin Microbiol. 1997;35:132–138. doi: 10.1128/jcm.35.1.132-138.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Crucitti T, Van Dyck E, Tehe A, Abdellati S, Vuylsteke B, et al. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect. 2003;79:393–398. doi: 10.1136/sti.79.5.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.UNAIDS/WHO Epidemiological Fact Sheet on HIV and AIDS, Zambia, 2008 update [Google Scholar]
  • 18.Crucitti T, Jespers V, Mulenga C, Khondowe S, Vandepitte J, et al. Trichomonas vaginalis is highly prevalent in adolescent girls, pregnant women and commercial sex workers in Ndola, Zambia. Sex Transm Dis. 2010;37:223–227. doi: 10.1097/OLQ.0b013e3181c21f93. [DOI] [PubMed] [Google Scholar]
  • 19.Adu-Sarkodie Y, Opoku BK, Crucitti T, Weiss HA, Mabey D. Lack of evidence for the involvement of rectal and oral trichomonads in the aetiology of vaginal trichomoniasis in Ghana. Sex Transm Infect. 2007;83:130–132. doi: 10.1136/sti.2006.020941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Peterson K, Drame D. Iatrogenic transmission of Trichomonas vaginalis by a traditional healer. Sec Transm Infect. 2010;86:353–354. doi: 10.1136/sti.2010.043125. [DOI] [PubMed] [Google Scholar]
  • 21.Cotch MF, Pastorek JG, Nugent RP, Hillier SL, Gibbs RS, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis. 1997;24:353–360. doi: 10.1097/00007435-199707000-00008. [DOI] [PubMed] [Google Scholar]
  • 22.Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993;7:95–102. doi: 10.1097/00002030-199301000-00015. [DOI] [PubMed] [Google Scholar]
  • 23.Rottingen JA, Cameron WD, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV, How much really is known? Sex Transm Dis. 2001;28:579–597. doi: 10.1097/00007435-200110000-00005. [DOI] [PubMed] [Google Scholar]
  • 24.Van der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis. 2008;197:548–554. doi: 10.1086/526496. [DOI] [PubMed] [Google Scholar]
  • 25.Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet. 1997;349:1868–1873. doi: 10.1016/s0140-6736(97)02190-9. [DOI] [PubMed] [Google Scholar]
  • 26.Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009;36:11–16. doi: 10.1097/OLQ.0b013e318186decf. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis. 2001;183:1017–1022. doi: 10.1086/319287. [DOI] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES